Cargando…

Serum levels of retinol-binding protein 4 and the risk of non-small cell lung cancer: A case-control study

Retinol binding protein 4 (RBP4), as an adipokine, has been identified to be associated with several types of cancer. However, no studies have assessed its effect on non-small cell lung cancer (NSCLC) risk. The objective of this study was to assess the association between serum RBP4 levels and the r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Xiaoping, Huang, Wenjun, Wang, Feng, Dai, Yifei, Hu, Xiaocong, Yue, Daoyuan, Wang, Shaomin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2020
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7402748/ https://www.ncbi.nlm.nih.gov/pubmed/32756103 http://dx.doi.org/10.1097/MD.0000000000021254

Ejemplares similares

(18)F-FDG uptake for prediction EGFR mutation status in non-small cell lung cancer
por: Guan, Jian, et al.
Publicado: (2016)

Correlation of microRNA-335 expression level with clinical significance and prognosis in non-small cell lung cancer
por: Huo, Wen, et al.
Publicado: (2020)

S-1-based concurrent chemoradiotherapy in the treatment of locally advanced non-small cell lung cancer: A systematic review and meta-analysis protocol
por: Liu, Feiyu, et al.
Publicado: (2018)

The role of serum angiopoietin-2 levels in progression and prognosis of lung cancer: A meta-analysis
por: Xu, Yuyang, et al.
Publicado: (2017)

Change in expressional level and clinicopathological significance of miR-193b-3p in non-small cell lung cancer
por: Xiao, Feng, et al.
Publicado: (2023)

The prognostic value of the serum neuron specific enolase and lactate dehydrogenase in small cell lung cancer patients receiving first-line platinum-based chemotherapy
por: Liu, Xiaofan, et al.
Publicado: (2017)

Construction of a nomogram to predict the prognosis of non-small-cell lung cancer with brain metastases
por: Huang, Zhangheng, et al.
Publicado: (2020)

Prognostic significance of PD-L1 in advanced non-small cell lung carcinoma
por: Zhao, Yanjie, et al.
Publicado: (2020)

Adverse cardiac events in the treatment of non-small cell lung cancer with programmed death-1and programmed death-ligand 1 inhibitors: A protocol for systematic review and meta-analysis
por: Li, Honglin, et al.
Publicado: (2020)

Temozolomide plus whole brain radiotherapy for the treatment of non-small-cell lung cancer patients with brain metastases: A protocol of an updated systematic review and meta-analysis
por: Duan, Hua, et al.
Publicado: (2020)

Integrated analysis of competitive endogenous RNA networks in elder patients with non-small cell lung cancer
por: Chen, Zi, et al.
Publicado: (2023)

Predictors for survival in patients with bone metastasis of small cell lung cancer: A population-based study
por: Xue, MingFeng, et al.
Publicado: (2021)

Distinct expression and prognostic value of members of SMAD family in non-small cell lung cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

Complete response of radioresistant brain metastases from non-small cell lung cancer with temozolomide: A case report and literature review
por: Yang, Yi, et al.
Publicado: (2020)

Lentinan combined with cisplatin for the treatment of non-small cell lung cancer
por: Zhao, Chenchen, et al.
Publicado: (2021)

Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis
por: Hu, Yongqi, et al.
Publicado: (2022)

Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Chao, Dong, et al.
Publicado: (2021)

Increased serum nesfatin-1 levels in patients with acromegaly
por: Yang, Yakun, et al.
Publicado: (2020)

Apatinib is effective as third-line and more treatment of advanced metastatic non-small-cell lung cancer: A retrospective analysis in a real-world setting
por: Leng, Jiao, et al.
Publicado: (2019)

Expression of LRIG1 is Associated With Good Prognosis for Human Non-small Cell Lung Cancer
por: An, Yuzhi, et al.
Publicado: (2015)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

Aberrant serum and tissue levels of Beclin1 and mechanistic target of rapamycin (mTOR) proteins in epithelial ovarian cancer
por: Lu, Huixia, et al.
Publicado: (2023)

Small-cell lung cancer transformation from EGFR-mutant adenocarcinoma after EGFR-TKIs resistance: A case report
por: Jiang, Yiqian, et al.
Publicado: (2021)

Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2015)

Plasma angiopoietin-2 is persistently elevated after non-small cell lung cancer surgery and stimulates angiogenesis in vitro
por: Zhou, Leng, et al.
Publicado: (2016)

Excessive splenic volume is an unfavorable prognostic factor in patients with non-small cell lung cancer treated with chemoradiotherapy
por: Guo, Jianping, et al.
Publicado: (2020)

The relationship between NLR/PLR/LMR levels and survival prognosis in patients with non-small cell lung carcinoma treated with immune checkpoint inhibitors
por: Liu, Na, et al.
Publicado: (2022)

Definitive local therapy for extracranial single-organ oligorecurrent non-small-cell lung cancer: A single institutional retrospective study
por: Jin, Jia-Nan, et al.
Publicado: (2022)

Splicing factor proline- and glutamine-rich regulates cytotoxic T lymphocytes-mediated cytotoxicity on non-small cell lung cancer by directly binding to PD-L1 3’UTR
por: Pan, Yanming, et al.
Publicado: (2023)

High pretreatment D-dimer level is an independent unfavorable prognostic factor of small cell lung cancer: A systematic review and meta-analysis
por: Deng, Han-Yu, et al.
Publicado: (2021)

Comparative study of the genomic landscape and tumor microenvironment among large cell carcinoma of the lung, large cell neuroendocrine of the lung, and small cell lung cancer
por: Li, Fanghua, et al.
Publicado: (2023)

The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015)

The effectiveness and safety of lienal polypeptide combined with chemotherapy or chemoradiotherapy for non-small cell lung cancer patients in real world
por: Wang, Zhe, et al.
Publicado: (2021)

Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study
por: He, Jinlin, et al.
Publicado: (2021)

Plasma miR-32 levels in non-small cell lung cancer patients receiving platinum-based chemotherapy can predict the effectiveness and prognosis of chemotherapy
por: Xu, Shuyuan, et al.
Publicado: (2019)

Five-hub genes identify potential mechanisms for the progression of asthma to lung cancer
por: Yang, Weichang, et al.
Publicado: (2023)

Plasma levels of soluble programmed death ligand-1 may be associated with overall survival in nonsmall cell lung cancer patients receiving thoracic radiotherapy
por: Zhao, Jing, et al.
Publicado: (2017)

Prognostic Value of Metastatic N1 Lymph Node Ratio and Angiolymphatic Invasion in Patients With Pathologic Stage IIA Non-Small Cell Lung Cancer
por: Wu, Ching-Feng, et al.
Publicado: (2014)

Response to toripalimab combined with radiotherapy in advanced non-small cell lung cancer-not otherwise specified: A case report
por: Jin, Yonglong, et al.
Publicado: (2021)

Optimum cycles of induction chemotherapy in concurrent chemo-radiotherapy management of unresectable stage III non-small cell lung cancer: Results from a single institutional database
por: Yacouba, Mohamed Bassirou Moukeila, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k6kf1i6tr1838nbqidmrfnb30d